Jose Lutzky, MD, discusses the importance of proactive patient monitoring with patients receiving immunotherapy treatments.
Jose Lutzky, MD, from Mount Sinai Medical Center, discusses the best practices for monitoring patients on immunotherapy.
With treatments that are potentially very toxic, it is important to develop a plan for following up with the patients. Every patient is different and some will need closer monitoring than others. Nurses shouldn’t rely on the patient to reach out to them, either. For treatments that could possibly result in these kinds of adverse events, it is better to take a more proactive approach to patient monitoring.
Patients With uHCC Who Experience irAEs With Tremelimumab/Durvalumab Achieve Numerical Improvements in OS
Adding Ribociclib to Endocrine Therapy Yields 25% Relative Reduction in Risk of Invasive Disease In Patients With HR+/HER2– Early Breast Cancer
Simple Hysterectomy May Replace Radical Hysterectomy as Standard of Care in Low-Risk, Early-Stage Cervical Cancer
Ridad and McKaig Discuss Oncology Nurse Perceptions on Medical Cannabis
2 Clarke Drive
Cranbury, NJ 08512